Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
excretion as metabolites only Apparent population mean clearance of 0.061 L/h The majority of the administered dose is recovered within 480 hours (approximately 20 days) following a single subcutaneous dose in human studies
For research use only - not for human consumption
Get a sneak peek into key market insights with our free sample report: The market is fueled by factors including increasing cases of type 2 diabetes and obesity, along with the combined advantages of these agonists in glycemic control and weight management
Gallbladder disease (including cholelithiasis and cholecystitis) has been reported, particularly with substantial weight loss
US$ 21.73
US$ 29.55
US$ 24.37
US$ 23.88
